Connection

SANDEEP AGARWAL to Humans

This is a "connection" page, showing publications SANDEEP AGARWAL has written about Humans.
Connection Strength

0.560
  1. Interpretable Ensemble Machine Learning Prediction of Nonadherence and the Risk of Nonpersistence of Targeted Disease-Modifying Antirheumatic Agents in Older Adults With Rheumatoid Arthritis. Clin Ther. 2026 Mar; 48(3):214-225.
    View in: PubMed
    Score: 0.026
  2. Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus. Lupus. 2025 Dec; 34(14):1437-1444.
    View in: PubMed
    Score: 0.025
  3. Insights into the genetic landscape of systemic sclerosis. Best Pract Res Clin Rheumatol. 2024 12; 38(4):101981.
    View in: PubMed
    Score: 0.023
  4. Factors Associated With Adherence of Cervical Cancer Screening in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2024 09; 76(9):1224-1231.
    View in: PubMed
    Score: 0.023
  5. CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus. J Autoimmun. 2024 05; 145:103197.
    View in: PubMed
    Score: 0.023
  6. Sacroiliac involvement in Blau Syndrome. Joint Bone Spine. 2021 03; 88(2):105103.
    View in: PubMed
    Score: 0.018
  7. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'. Ann Rheum Dis. 2022 12; 81(12):e239.
    View in: PubMed
    Score: 0.018
  8. Macrophages and cadherins in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 11; 31(6):582-588.
    View in: PubMed
    Score: 0.017
  9. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride. PLoS One. 2019; 14(7):e0218971.
    View in: PubMed
    Score: 0.016
  10. Acral enlargement without growth hormone excess: a clinical conundrum. BMJ Case Rep. 2019 Apr 11; 12(4).
    View in: PubMed
    Score: 0.016
  11. Role of STAT3 in skin fibrosis and transforming growth factor beta signalling. Rheumatology (Oxford). 2018 10 01; 57(10):1838-1850.
    View in: PubMed
    Score: 0.016
  12. Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model. PLoS One. 2017; 12(11):e0187109.
    View in: PubMed
    Score: 0.015
  13. Double Trouble: The Diagnostic Dilemma of Diffuse Alveolar Hemorrhage. Am J Med. 2016 Jul; 129(7):e73-4.
    View in: PubMed
    Score: 0.013
  14. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis. Arthritis Rheumatol. 2014 Apr; 66(4):1010-21.
    View in: PubMed
    Score: 0.011
  15. Osteopontin in systemic sclerosis and its role in dermal fibrosis. J Invest Dermatol. 2012 Jun; 132(6):1605-14.
    View in: PubMed
    Score: 0.010
  16. Core management principles in rheumatoid arthritis to help guide managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S03-8.
    View in: PubMed
    Score: 0.010
  17. Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S09-13.
    View in: PubMed
    Score: 0.010
  18. Biologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S14-8.
    View in: PubMed
    Score: 0.010
  19. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012 Feb; 26(2):503-12.
    View in: PubMed
    Score: 0.010
  20. Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts. J Rheumatol. 2011 Jun; 38(6):1033-8.
    View in: PubMed
    Score: 0.009
  21. Stress and autoimmunity. Immunol Allergy Clin North Am. 2011 Feb; 31(1):1-18.
    View in: PubMed
    Score: 0.009
  22. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Arthritis Res Ther. 2011 Jan 11; 13(1):R3.
    View in: PubMed
    Score: 0.009
  23. The genetics of systemic sclerosis. Discov Med. 2010 Aug; 10(51):134-43.
    View in: PubMed
    Score: 0.009
  24. The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol. 2010 Mar; 22(2):133-8.
    View in: PubMed
    Score: 0.009
  25. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. J Rheumatol. 2009 Dec; 36(12):2715-23.
    View in: PubMed
    Score: 0.008
  26. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther. 2009; 11(5):R147.
    View in: PubMed
    Score: 0.008
  27. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis. 2010 Mar; 69(3):550-5.
    View in: PubMed
    Score: 0.008
  28. Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol. 2008 Sep; 35(9):1737-44.
    View in: PubMed
    Score: 0.008
  29. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am. 2008 Feb; 34(1):17-40; v.
    View in: PubMed
    Score: 0.007
  30. Role of adhesion molecules in synovial inflammation. Curr Opin Rheumatol. 2006 May; 18(3):268-76.
    View in: PubMed
    Score: 0.007
  31. Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center. Arthritis Rheum. 2005 Dec 15; 53(6):872-8.
    View in: PubMed
    Score: 0.006
  32. Characterization of relapses in adult idiopathic inflammatory myopathies. Clin Rheumatol. 2006 Jul; 25(4):476-81.
    View in: PubMed
    Score: 0.006
  33. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1201-1213.
    View in: PubMed
    Score: 0.006
  34. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1070-1082.
    View in: PubMed
    Score: 0.006
  35. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1051-1069.
    View in: PubMed
    Score: 0.006
  36. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1182-1200.
    View in: PubMed
    Score: 0.006
  37. Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006-2019 United States National Data. Arthritis Care Res (Hoboken). 2024 10; 76(10):1427-1435.
    View in: PubMed
    Score: 0.006
  38. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis. J Control Release. 2024 Jun; 370:110-123.
    View in: PubMed
    Score: 0.006
  39. Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clin Ther. 2023 09; 45(9):e177-e186.
    View in: PubMed
    Score: 0.005
  40. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116.
    View in: PubMed
    Score: 0.005
  41. Mesenteric lipoblastomatosis: an uncommon fat-containing childhood tumour diagnosed on imaging. BMJ Case Rep. 2023 May 26; 16(5).
    View in: PubMed
    Score: 0.005
  42. Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A?systematic review. Int J Rheum Dis. 2023 Jun; 26(6):1022-1028.
    View in: PubMed
    Score: 0.005
  43. Oral delivery of RNAi for cancer therapy. Cancer Metastasis Rev. 2023 09; 42(3):699-724.
    View in: PubMed
    Score: 0.005
  44. IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis. J Invest Dermatol. 2023 09; 143(9):1689-1699.
    View in: PubMed
    Score: 0.005
  45. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition. Cancer Res. 2022 09 02; 82(17):3158-3171.
    View in: PubMed
    Score: 0.005
  46. The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review. Lupus. 2022 Sep; 31(10):1163-1174.
    View in: PubMed
    Score: 0.005
  47. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021 Jul 26; 14(7).
    View in: PubMed
    Score: 0.005
  48. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Ann Rheum Dis. 2019 11; 78(11):1583-1591.
    View in: PubMed
    Score: 0.004
  49. Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing. Arthritis Rheumatol. 2019 04; 71(4):529-541.
    View in: PubMed
    Score: 0.004
  50. The Antifibrotic Effect of A2B Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis. Arthritis Rheumatol. 2018 10; 70(10):1673-1684.
    View in: PubMed
    Score: 0.004
  51. Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. JCI Insight. 2017 12 07; 2(23).
    View in: PubMed
    Score: 0.004
  52. Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27. Clin Breast Cancer. 2018 02; 18(1):78-87.
    View in: PubMed
    Score: 0.004
  53. CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts. Arthritis Rheumatol. 2017 09; 69(9):1871-1878.
    View in: PubMed
    Score: 0.004
  54. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann Rheum Dis. 2017 May; 76(5):831-839.
    View in: PubMed
    Score: 0.003
  55. Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics. J Cell Sci. 2016 08 01; 129(15):2950-61.
    View in: PubMed
    Score: 0.003
  56. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J Immunol. 2014 Oct 01; 193(7):3755-68.
    View in: PubMed
    Score: 0.003
  57. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014 Jan 30; 370(5):433-43.
    View in: PubMed
    Score: 0.003
  58. Detection and isolation of auto-reactive human antibodies from primary B cells. Methods. 2013 Dec 01; 64(2):153-9.
    View in: PubMed
    Score: 0.003
  59. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012 Jul; 71(7):1197-202.
    View in: PubMed
    Score: 0.002
  60. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet. 2012 Feb 15; 21(4):926-33.
    View in: PubMed
    Score: 0.002
  61. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Ann Rheum Dis. 2012 Jan; 71(1):114-9.
    View in: PubMed
    Score: 0.002
  62. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011 Jul; 7(7):e1002178.
    View in: PubMed
    Score: 0.002
  63. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8):1622-30.
    View in: PubMed
    Score: 0.002
  64. Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol. 2011 Jan; 38(1):87-98.
    View in: PubMed
    Score: 0.002
  65. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010 May; 42(5):426-9.
    View in: PubMed
    Score: 0.002
  66. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum. 2010 Feb; 62(2):589-98.
    View in: PubMed
    Score: 0.002
  67. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum. 2009 Dec; 60(12):3794-806.
    View in: PubMed
    Score: 0.002
  68. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun. 2010 Mar; 34(2):155-62.
    View in: PubMed
    Score: 0.002
  69. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010 May; 69(5):822-7.
    View in: PubMed
    Score: 0.002
  70. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc Natl Acad Sci U S A. 2008 Aug 12; 105(32):11281-6.
    View in: PubMed
    Score: 0.002
  71. Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro. Am J Pathol. 2006 May; 168(5):1486-99.
    View in: PubMed
    Score: 0.002
  72. Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario. J Behav Med. 2003 Oct; 26(5):459-71.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.